Dr. Reddy's Laboratories Limited (NSE:DRREDDY)
India · Delayed Price · Currency is INR 1,211.20
-13.20 (-1.08%)
Jul 17, 2026, 3:29 PM IST
Dr. Reddy's Laboratories Employees
Dr. Reddy's Laboratories had 27,527 employees as of March 31, 2026. The number of employees decreased by 284 or -1.02% compared to the previous year.
Employees
27,527
Change (1Y)
-284
Growth (1Y)
-1.02%
Revenue / Employee
12.20M INR
Profits / Employee
1.56M INR
Market Cap
1.01T
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 27,527 | -284 | -1.02% |
| Mar 31, 2025 | 27,811 | 763 | 2.82% |
| Mar 31, 2024 | 27,048 | 1,185 | 4.58% |
| Mar 31, 2023 | 25,863 | 1,068 | 4.31% |
| Mar 31, 2022 | 24,795 | 2,056 | 9.04% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cipla | 31,369 |
| Zydus Lifesciences | 29,980 |
| Aurobindo Pharma | 27,707 |
| Mankind Pharma | 20,451 |
| Alkem Laboratories | 18,785 |
| Ipca Laboratories | 16,778 |
| Glenmark Pharmaceuticals | 15,800 |
| Divi's Laboratories | 10,542 |
Dr. Reddy's Laboratories News
- 3 days ago - Top stocks to buy today: Stock recommendations for July 15, 2026 - check list - The Times of India
- 5 days ago - Dr. Reddy's Laboratories Flags Semaglutide Supply Delay, Says No Recall Risk - MarketBeat
- 8 days ago - India's Dr Reddy's extends slide as semaglutide setback threatens first-mover edge - Reuters
- 8 days ago - Dr. Reddy's Laboratories (RDY) Faces Supply Delays Due to Quality Issues - GuruFocus
- 9 days ago - India's Torrent Pharma recalls select semaglutide pens after Dr. Reddy's notice - Reuters
- 9 days ago - Dr. Reddy's Laboratories Transcript: Investor update - Transcripts
- 9 days ago - Dr. Reddy’s Generic Ozempic Supplies Delayed on API Issue - Financial Post
- 9 days ago - Dr Reddy's delays semaglutide supply due to active ingredient issue - Reuters